ConductScience.org, home

Paper36928816

A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer.

Assaf ZJF and 18 others. Nat Med, 2023. Cited by 142 papers, by iCite.

Cite this record

ConductScience Library. A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer. Papers, record 36928816. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36928816

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer.
PubMed
Journal
Nat Med
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
142
iCite
Relative citation ratio, by iCite
11.2
iCite
Revised in PubMed
2023-10-24
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Assaf ZJFZoe June F
2Zou WWeihttps://orcid.org/0000-0002-3639-9821
3Fine ADAlexander D
4Socinski MAMark A
5Young AAmandahttps://orcid.org/0000-0002-2199-1873
6Lipson DDoron
7Freidin JFJonathan Fhttps://orcid.org/0000-0003-1821-8932
8Kennedy MMark
9Polisecki EEliana
10Nishio MMakoto
11Fabrizio DDavid
12Oxnard GRGeoffrey R
13Cummings CCraig
14Rode AAnja
15Reck MMartin
16Patil NSNamrata S
17Lee MMark
18Shames DSDavid Shttps://orcid.org/0000-0002-5900-1177
19Schulze KKatjahttps://orcid.org/0000-0003-3704-5651

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
Circulating Tumor DNAMajor topic
Lung NeoplasmsMajor topic
Humans
Biomarkers, Tumor

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in37059837High-resolution circulating tumor DNA testing predicts survival in metastatic lung cancer clinical trials.https://conductscience.org/library/papers/37059837

Source PubMed

Download CSV of comments and corrections

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119097774New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer2009https://conductscience.org/library/papers/19097774PubMed
222952221Why RECIST works and why it should stay--counterpoint.Cancer Res2012https://conductscience.org/library/papers/22952221PubMed
326261262Pseudoprogression and Immune-Related Response in Solid Tumors.J Clin Oncol2015https://conductscience.org/library/papers/26261262PubMed
429182990Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria.Eur J Cancer2018https://conductscience.org/library/papers/29182990PubMed
531157275Surrogate endpoints in immunotherapy trials for solid tumors.Ann Transl Med2019https://conductscience.org/library/papers/31157275PubMed
630453169Evaluation of objective response, disease control and progression-free survival as surrogate end-points for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials.Eur J Cancer2019https://conductscience.org/library/papers/30453169PubMed
730380390Application of Cell-free DNA Analysis to Cancer Treatment.N Engl J Med2018https://conductscience.org/library/papers/30380390PubMed
828233803Liquid biopsies come of age: towards implementation of circulating tumour DNA.Nat Rev Cancer2017https://conductscience.org/library/papers/28233803PubMed
931621801Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.JAMA Oncol2019https://conductscience.org/library/papers/31621801PubMed
1031369045Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.JAMA Oncol2019https://conductscience.org/library/papers/31369045PubMed
1128445469Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.Nature2017https://conductscience.org/library/papers/28445469PubMed
1232807235Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression.Genome Med2020https://conductscience.org/library/papers/32807235PubMed
1333211112Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.JAMA Netw Open2020https://conductscience.org/library/papers/33211112PubMed
1433659207Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer.Front Oncol2020https://conductscience.org/library/papers/33659207PubMed
1534135506ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.Nature2021https://conductscience.org/library/papers/34135506PubMed
1631059311Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma.J Clin Oncol2019https://conductscience.org/library/papers/31059311PubMed
1733232761Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival.Ann Oncol2021https://conductscience.org/library/papers/33232761PubMed
1831758080Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer.Sci Rep2019https://conductscience.org/library/papers/31758080PubMed
1932420063EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib.Transl Lung Cancer Res2020https://conductscience.org/library/papers/32420063PubMed
2035121950Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab.Nat Cancer2020https://conductscience.org/library/papers/35121950PubMed

See all 42 referencesDownload CSV of references

Cited by104

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 142 citations.

PMIDTitleJournalYearIn PapersSource
42854587Nivolumab in patients with advanced solid tumors with ctDNA-defined high blood tumor mutational burden: a phase II trial.ESMO Open2026https://conductscience.org/library/papers/42854587PubMed
42803873Applications of circulating tumor DNA in unresectable and advanced non-small cell lung cancer immunotherapy: from stratification to therapeutic guidance.Clin Transl Oncol2026https://conductscience.org/library/papers/42803873PubMed
42724192Molecular differences between poorly and well/moderately differentiated lung adenocarcinoma and their clinical implications.J Thorac Dis2026https://conductscience.org/library/papers/42724192PubMed
42694453Circulating tumor DNA in lung cancer immunotherapy: prognostic marker today, predictive tool tomorrow?Front Immunol2026https://conductscience.org/library/papers/42694453PubMed
42647763Molecular Response Assessment From Circulating Tumor DNA in Patients With Ovarian Cancer Treated With the WEE1 Inhibitor Azenosertib.JCO Precis Oncol2026https://conductscience.org/library/papers/42647763PubMed
42539610Application of deep learning in prognostic prediction of non-small cell lung cancer.Front Cell Dev Biol2026https://conductscience.org/library/papers/42539610PubMed
42532630Combined circulating tumor antigen model demonstrates additional prognostic value in first-line treatment of non-small cell lung cancer.J Immunother Cancer2026https://conductscience.org/library/papers/42532630PubMed
42416486Predictive value of baseline levels and early dynamic changes of ctDNA for 28-day mortality in ICU patients with advanced lung cancer: a prospective single-center cohort study.Front Mol Biosci2026https://conductscience.org/library/papers/42416486PubMed
42395173Longitudinal methylated ctDNA increases predict immunotherapy progression across solid tumors.J Liq Biopsy2026https://conductscience.org/library/papers/42395173PubMed
42353230The Predictive Role of ctDNA and CTCs in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy: A Systematic Review and Meta-Analysis.Int J Mol Sci2026https://conductscience.org/library/papers/42353230PubMed
42218435Extracellular vesicle and particle biomarkers in cancer: a machine learning blueprint for liquid biopsy.J Nanobiotechnology2026https://conductscience.org/library/papers/42218435PubMed
42180855Clinical significance of circulating tumor DNA monitoring based on TP53 mutation in high-grade serous ovarian cancer patients.Transl Cancer Res2026https://conductscience.org/library/papers/42180855PubMed
42176127Somatic mutation profiling by NGS-based liquid biopsy in advanced non-small cell lung cancer: frequency, clinical correlates, and prognostic significance.Mol Biol Rep2026https://conductscience.org/library/papers/42176127PubMed
42127914Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.Cancer Res Commun2026https://conductscience.org/library/papers/42127914PubMed
42073604Advances in Multi-Modal Biomarkers for Immunotherapy Response in Non-Small Cell Lung Cancer: ctDNA, Microbiome, and Radiomics.Cancers (Basel)2026https://conductscience.org/library/papers/42073604PubMed
41878015Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer.Immunotargets Ther2026https://conductscience.org/library/papers/41878015PubMed
41859746Correlation Analysis Between Circulating Tumor DNA and Prognosis in Patients with Hepatocellular Carcinoma.Cancer Manag Res2026https://conductscience.org/library/papers/41859746PubMed
41820395ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer.Nat Commun2026https://conductscience.org/library/papers/41820395PubMed
41721022Implementation of a 1021-gene liquid biopsy assay for real-world tumor genomic profiling in oncology practice.Sci Rep2026https://conductscience.org/library/papers/41721022PubMed
41649698Interpretable deep learning model of circulating genomics for quantitative survival prediction in advanced non-small cell lung cancer.Clin Transl Oncol2026https://conductscience.org/library/papers/41649698PubMed

See all 104 cited byDownload CSV of cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
ASXL1171023PubTator's text mininghttps://conductscience.org/library/genes/171023NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
CBL867PubTator's text mininghttps://conductscience.org/library/genes/867NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CHEK211200PubTator's text mininghttps://conductscience.org/library/genes/11200NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
DNMT3A1788PubTator's text mininghttps://conductscience.org/library/genes/1788NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
FAT12195PubTator's text mininghttps://conductscience.org/library/genes/2195NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
KMT2C58508PubTator's text mininghttps://conductscience.org/library/genes/58508NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
PPM1D8493PubTator's text mininghttps://conductscience.org/library/genes/8493NCBI Gene
SF3B123451PubTator's text mininghttps://conductscience.org/library/genes/23451NCBI Gene
STK116794PubTator's text mininghttps://conductscience.org/library/genes/6794NCBI Gene
TET254790PubTator's text mininghttps://conductscience.org/library/genes/54790NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36928816

GET https://conductscience.org/api/papers/v1/36928816/references?page=2